COM:AKOYABIO
Akoya Biosciences, Inc.
- Stock
Last Close
2.16
21/11 21:00
Market Cap
102.72M
Beta: -
Volume Today
135.36K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | 4.18M - | 6.64M 58.89% | 11.75M 77.00% | 16.18M 37.71% | ||
average payables | 6.60M - | 14.14M 114.30% | 25.17M 78.07% | 19.46M 22.69% | ||
average receivables | 9.82M - | 7.96M 18.96% | 9.59M 20.48% | 13.36M 39.38% | ||
book value per share | -1.04 - | 0.64 161.58% | 4.51 602.50% | 1.55 65.60% | 0.00 99.92% | |
capex per share | -0.10 - | -0.11 14.85% | -0.19 66.20% | -0.19 2.95% | -0.00 99.96% | |
capex to depreciation | -0.94 - | -0.86 8.03% | -1.06 23.08% | -1.03 3.15% | -0.41 60.09% | |
capex to operating cash flow | 0.21 - | 0.48 131.21% | 0.14 70.67% | 0.14 2.59% | 0.07 47.83% | |
capex to revenue | -0.07 - | -0.08 14.29% | -0.09 19.48% | -0.10 5.99% | -0.04 61.55% | |
cash per share | 0.75 - | 0.59 21.48% | 4.20 614.85% | 2.15 48.82% | 0.00 99.91% | |
days of inventory on hand | 85.01 - | 94.10 10.69% | 158.95 68.91% | 168.02 5.71% | 161.80 3.70% | |
days payables outstanding | 168.64 - | 112.01 33.58% | 409.07 265.22% | 314.87 23.03% | 106.58 66.15% | |
days sales outstanding | 113.79 - | 55.64 51.10% | 62.77 12.81% | 47.44 24.43% | 64.19 35.32% | |
debt to assets | 0.28 - | 0.45 62.78% | 0.17 61.94% | 0.43 151.01% | 0.48 10.37% | |
debt to equity | -0.82 - | 1.88 329.61% | 0.27 85.68% | 1.29 379.45% | 1.59 23.21% | |
dividend yield | 0.00 - | |||||
earnings yield | -0.03 - | -0.03 13.25% | -0.10 260.94% | -0.20 87.56% | -0.00 99.85% | |
enterprise value | 591.44M - | 596.31M 0.82% | 331.18M 44.46% | 362.79M 9.54% | 216.84B 59,670.53% | |
enterprise value over ebitda | -54.65 - | -78.07 42.85% | -10.06 87.11% | -6.11 39.24% | -3.39K 55,261.71% | |
ev to operating cash flow | -42.93 - | -87.14 102.97% | -9.18 89.46% | -6.78 26.14% | -4.26K 62,720.18% | |
ev to sales | 14.00 - | 14.05 0.33% | 6.03 57.08% | 4.85 19.64% | 2.24K 46,202.63% | |
free cash flow per share | -0.58 - | -0.35 39.09% | -1.53 336.50% | -1.61 5.35% | -0.00 99.92% | |
free cash flow yield | -0.03 - | -0.02 39.09% | -0.10 470.21% | -0.17 68.54% | -0.00 99.85% | |
graham net net | -2.97 - | -1.21 59.18% | 2.05 268.81% | -0.57 128.05% | -0.00 99.91% | |
graham number | 3.46 - | 2.89 16.49% | 12.73 340.57% | 8.08 36.50% | 0.01 99.92% | |
income quality | 0.93 - | 0.41 56.14% | 0.84 105.09% | 0.76 9.85% | 0.80 6.14% | |
intangibles to total assets | 0.47 - | 0.53 11.27% | 0.21 60.87% | 0.22 5.42% | 0.20 9.12% | |
interest coverage | -7.18 - | -4.22 41.21% | -11.95 183.16% | -14.54 21.66% | 6.58 145.28% | |
interest debt per share | 0.92 - | 1.30 41.62% | 1.33 2.21% | 2.13 59.65% | 0.00 99.92% | |
inventory turnover | 4.29 - | 3.88 9.66% | 2.30 40.80% | 2.17 5.40% | 2.26 3.84% | |
invested capital | -0.82 - | 1.88 329.61% | 0.27 85.68% | 1.29 379.45% | 1.59 23.21% | |
market cap | 578.32M - | 578.32M 0% | 411.79M 28.80% | 361.24M 12.28% | 216.84B 59,927.11% | |
net current asset value | -78.70M - | -30.39M 61.38% | 71.26M 334.46% | -5.25M 107.37% | -4.81M 8.45% | |
net debt to ebitda | -1.21 - | -2.36 94.33% | 2.45 204.01% | -0.03 101.07% | -0.04 53.74% | |
net income per share | -0.51 - | -0.58 13.25% | -1.60 176.30% | -1.87 17.24% | -0.00 99.92% | |
operating cash flow per share | -0.48 - | -0.24 50.33% | -1.34 466.65% | -1.42 5.69% | -0.00 99.92% | |
payables turnover | 2.16 - | 3.26 50.56% | 0.89 72.62% | 1.16 29.92% | 3.42 195.43% | |
receivables turnover | 3.21 - | 6.56 104.51% | 5.82 11.36% | 7.69 32.32% | 5.69 26.10% | |
research and ddevelopement to revenue | 0.21 - | 0.23 9.08% | 0.29 26.36% | 0.31 8.45% | 0.23 26.94% | |
return on tangible assets | -0.31 - | -0.46 45.14% | -0.28 37.77% | -0.51 80.99% | -0.44 14.68% | |
revenue per share | 1.46 - | 1.47 0.49% | 2.04 39.10% | 1.98 2.87% | 0.00 99.89% | |
roe | 0.49 - | -0.90 283.92% | -0.35 60.67% | -1.21 240.83% | -1.18 2.34% | |
roic | 2.67 - | -0.21 107.98% | -0.24 12.60% | -0.45 88.11% | -0.38 14.88% | |
sales general and administrative to revenue | ||||||
shareholders equity per share | -1.04 - | 0.64 161.58% | 4.51 602.50% | 1.55 65.60% | 0.00 99.92% | |
stock based compensation to revenue | 0.00 - | 0.01 210.24% | 0.07 554.42% | 0.10 34.95% | 0.11 8.82% | |
tangible asset value | -72.56M - | -22.41M 69.12% | 81.94M 465.72% | 20.27M 75.26% | 18.10M 10.73% | |
tangible book value per share | -2.51 - | -0.77 69.12% | 3.05 493.17% | 0.54 82.37% | 0.00 99.92% | |
working capital | 19.72M - | 11.53M 41.51% | 113.13M 880.86% | 75.14M 33.58% | 86.44M 15.04% |
All numbers in (except ratios and percentages)